Table 2.
Variable | HR2 | 95% CI3 | P value |
---|---|---|---|
Univariate analysis | |||
Age (≤66.3 vs >66.3) | 0.998 | 0.985-1.011 | 0.772 |
Sex (female vs male) | 1.212 | 0.916-1.604 | 0.179 |
Tumor size (≤5 vs >5 cm) | 0.827 | 0.621-1.101 | 0.193 |
Tumor differentiation (well/moderate vs poor) | 0.186 | 0.139-0.249 | <0.001 |
Tumor invasion (T1-T3 vs T4) | 0.357 | 0.265-0.480 | <0.001 |
Lymph node metastasis (absent vs present) | 0.136 | 0.098-0.189 | <0.001 |
Distant metastasis (absent vs present) | 0.113 | 0.081-0.157 | <0.001 |
AJCC4 stage (I-II vs III-Ⅳ) | 0.133 | 0.095-0.186 | <0.001 |
miR-139-5p expression (high vs low) | 0.250 | 0.187-0.333 | <0.001 |
Multivariate analysis | |||
Tumor differentiation (well/moderate vs poor) | 0.809 | 0.544-1.202 | 0.294 |
Tumor invasion (T1-T3 vs T4) | 0.669 | 0.218-2.058 | 0.484 |
Lymph node metastasis (absent vs present) | 0.336 | 0.114-0.984 | 0.047 |
Distant metastasis (absent vs present) | 0.485 | 0.314-0.749 | 0.001 |
AJCC stage (I-II vs III-Ⅳ) | 0.489 | 0.344-0.694 | <0.001 |
miR-139-5p expression (high vs low) | 0.415 | 0.300-0.576 | <0.001 |
1. CRC: Colorectal cancer.
2. HR: Hazard ratio.
3. CI: Confidence interval.
4. AJCC: American Joint Committee on Cancer.